首页 > 最新文献

Current opinion in microbiology最新文献

英文 中文
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2026-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"90 ","pages":"Article 102711"},"PeriodicalIF":7.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147066840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2026-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"89 ","pages":"Article 102717"},"PeriodicalIF":7.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147039963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2026-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"89 ","pages":"Article 102684"},"PeriodicalIF":7.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147039965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ecology of methyl-coenzyme M reductase encoding Thermoproteota 编码热变形菌的甲基辅酶M还原酶的生态学。
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2025-12-29 DOI: 10.1016/j.mib.2025.102699
Zackary J Jay , Matthew Kellom , Emiley Eloe-Fadrosh , Roland Hatzenpichler
The recent demonstration that members of at least three classes of archaea affiliated with the Thermoproteota superphylum are involved in the production of the climate-active gas methane has sparked discussions about how well we understand the diversity of methanogens. Here, we show that members of all three of these lineages, as well as several other, yet uncultured and physiologically uncharacterized groups within the Thermoproteota that encode the key enzyme of anaerobic methane cycling, methyl-coenzyme M reductase (MCR), are widely distributed in anoxic ecosystems. We postulate that the taxonomic, metabolic, and ecological diversity of methanogenic and MCR-encoding Thermoproteota are poorly understood, and that the contribution of methylotrophic and thermoproteotal methanogenesis to methane production is largely unknown. We hypothesize that thermoproteotal methanogens could contribute, potentially substantially, to methane emissions in many anoxic environments that harbor methylated precursors, including wetlands, sediments, peat, rice paddies, wastewater sludge, and geothermal systems. We highlight the necessity to experimentally test the (eco)physiology of these widely distributed archaea using both culture-dependent (in vitro) and culture-independent (in situ) approaches to assess their potential contribution to methane emissions. Last, we stress the importance of remaining agnostic about the physiology of MCR-encoding Thermoproteota in the absence of experimental data because most of these archaea also carry the genetic potential to grow non-methanogenically.
最近的一项研究表明,至少有三种属于热变形门的古细菌参与了气候活性气体甲烷的产生,这引发了关于我们对产甲烷菌多样性的了解程度的讨论。在这里,我们发现所有这三个谱系的成员,以及其他几个尚未培养和生理上未表征的热变形门类群,编码厌氧甲烷循环的关键酶甲基辅酶M还原酶(MCR),广泛分布在缺氧生态系统中。我们认为,产甲烷和编码mcr的热保护菌的分类、代谢和生态多样性尚不清楚,而甲基化和热保护菌的产甲烷作用在很大程度上是未知的。我们假设热保护产甲烷菌可能在许多缺氧环境中潜在地大量贡献甲烷排放,这些环境中含有甲基化前体,包括湿地、沉积物、泥炭、稻田、废水污泥和地热系统。我们强调有必要通过实验测试这些广泛分布的古细菌的(生态)生理学,使用培养依赖(体外)和培养独立(原位)的方法来评估它们对甲烷排放的潜在贡献。最后,我们强调在缺乏实验数据的情况下,对编码mcr的热变形菌的生理学保持不可知论的重要性,因为大多数这些古细菌也携带非甲烷生长的遗传潜力。
{"title":"Ecology of methyl-coenzyme M reductase encoding Thermoproteota","authors":"Zackary J Jay ,&nbsp;Matthew Kellom ,&nbsp;Emiley Eloe-Fadrosh ,&nbsp;Roland Hatzenpichler","doi":"10.1016/j.mib.2025.102699","DOIUrl":"10.1016/j.mib.2025.102699","url":null,"abstract":"<div><div>The recent demonstration that members of at least three classes of archaea affiliated with the Thermoproteota superphylum are involved in the production of the climate-active gas methane has sparked discussions about how well we understand the diversity of methanogens. Here, we show that members of all three of these lineages, as well as several other, yet uncultured and physiologically uncharacterized groups within the Thermoproteota that encode the key enzyme of anaerobic methane cycling, methyl-coenzyme M reductase (MCR), are widely distributed in anoxic ecosystems. We postulate that the taxonomic, metabolic, and ecological diversity of methanogenic and MCR-encoding Thermoproteota are poorly understood, and that the contribution of methylotrophic and thermoproteotal methanogenesis to methane production is largely unknown. We hypothesize that thermoproteotal methanogens could contribute, potentially substantially, to methane emissions in many anoxic environments that harbor methylated precursors, including wetlands, sediments, peat, rice paddies, wastewater sludge, and geothermal systems. We highlight the necessity to experimentally test the (eco)physiology of these widely distributed archaea using both culture-dependent (<em>in vitro</em>) and culture-independent (<em>in situ</em>) approaches to assess their potential contribution to methane emissions. Last, we stress the importance of remaining agnostic about the physiology of MCR-encoding Thermoproteota in the absence of experimental data because most of these archaea also carry the genetic potential to grow non-methanogenically.</div></div>","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"89 ","pages":"Article 102699"},"PeriodicalIF":7.5,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145862207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineering microbes to modulate innate immune signaling: strategies for host–microbe interactions 工程微生物调节先天免疫信号:宿主-微生物相互作用的策略。
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2025-12-22 DOI: 10.1016/j.mib.2025.102695
Shanna Bonanno , Neel S Joshi
The human gastrointestinal tract hosts a dense microbial community that closely interfaces with the mucosal immune system to preserve homeostasis. While dysregulation of this interaction contributes to certain disease states, through targeted microbial engineering, these interactions can be modulated for therapeutic benefit. Although engineered microbial therapeutics have shown encouraging preclinical results, few approaches have progressed into clinical pipelines. This gap highlights the need for engineered microbes with greater precision, reliability, and context-dependent control. The innate immune system is primed to rapidly sense microbial signals through pattern recognition receptors and provides accessible and tractable targets for such interventions. This review highlights four strategies that have used engineered probiotics to modulate innate immunity: (1) direct immune cell engagement through surface-display, (2) production of soluble immune effectors, (3) extracellular vesicles for delivery of immune modulators, and (4) environmentally responsive systems to enable spatial and temporal control over immune modulation. Bridging microbial engineering with mucosal immunology can enable engineered probiotics to function as dynamic, context-aware immunomodulators.
人类胃肠道拥有密集的微生物群落,与粘膜免疫系统紧密结合以保持体内平衡。虽然这种相互作用的失调会导致某些疾病状态,但通过靶向微生物工程,可以调节这些相互作用以获得治疗益处。尽管工程微生物疗法已经显示出令人鼓舞的临床前结果,但很少有方法进入临床管道。这一差距突出了对具有更高精度、可靠性和环境依赖控制的工程微生物的需求。先天免疫系统通过模式识别受体快速感知微生物信号,并为此类干预提供了可接近和可处理的靶标。这篇综述强调了使用工程益生菌调节先天免疫的四种策略:(1)通过表面展示直接参与免疫细胞;(2)产生可溶性免疫效应器;(3)细胞外囊泡递送免疫调节剂;(4)环境响应系统实现对免疫调节的空间和时间控制。桥接微生物工程与粘膜免疫学可以使工程益生菌作为动态的,环境敏感的免疫调节剂的功能。
{"title":"Engineering microbes to modulate innate immune signaling: strategies for host–microbe interactions","authors":"Shanna Bonanno ,&nbsp;Neel S Joshi","doi":"10.1016/j.mib.2025.102695","DOIUrl":"10.1016/j.mib.2025.102695","url":null,"abstract":"<div><div>The human gastrointestinal tract hosts a dense microbial community that closely interfaces with the mucosal immune system to preserve homeostasis. While dysregulation of this interaction contributes to certain disease states, through targeted microbial engineering, these interactions can be modulated for therapeutic benefit. Although engineered microbial therapeutics have shown encouraging preclinical results, few approaches have progressed into clinical pipelines. This gap highlights the need for engineered microbes with greater precision, reliability, and context-dependent control. The innate immune system is primed to rapidly sense microbial signals through pattern recognition receptors and provides accessible and tractable targets for such interventions. This review highlights four strategies that have used engineered probiotics to modulate innate immunity: (1) direct immune cell engagement through surface-display, (2) production of soluble immune effectors, (3) extracellular vesicles for delivery of immune modulators, and (4) environmentally responsive systems to enable spatial and temporal control over immune modulation. Bridging microbial engineering with mucosal immunology can enable engineered probiotics to function as dynamic, context-aware immunomodulators.</div></div>","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"89 ","pages":"Article 102695"},"PeriodicalIF":7.5,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145818490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nucleus-forming phages: from subcellular organization and viral–host interplay to prospects for phage applications 成核噬菌体:从亚细胞组织和病毒-宿主相互作用到噬菌体应用前景
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2025-12-19 DOI: 10.1016/j.mib.2025.102698
Vorrapon Chaikeeratisak , Poochit Nonejuie , Chase J Morgan
The increasing emergence of multidrug-resistant bacterial infections poses a major threat to humankind, with 10 million deaths predicted in 2050 as a result. Phage therapy has therefore regained attention as a promising approach to combat these pathogens. However, the ongoing evolutionary arms race between phages and bacteria has driven the accumulation of phage defense systems in bacterial populations, which can compromise the efficacy and generalizability of phage applications. Recently, nucleus-forming phages have been discovered and classified under the newly established phage family ‘Chimalliviridae’. Chimalliviruses orchestrate a highly organized, nucleus-based replication that physically segregates phage DNA from host defenses, thereby enhancing replication efficiency and conferring resistance to a wide array of host defenses. Their unique replication strategy and subcellular organization far exceed that of classical phages, positioning them as candidates for a new class of ‘next-generation phages’ with superior therapeutic potential and biocontrol capabilities. This review will cover the current landscape of chimallivirus discovery, highlighting their association with bacterial pathogens, unique replication machinery, and interaction with bacterial defenses. Furthermore, it provides insights into chimallivirus-based therapeutic applications.
越来越多的耐多药细菌感染对人类构成重大威胁,预计到2050年将造成1 000万人死亡。因此,噬菌体治疗作为对抗这些病原体的一种有希望的方法重新引起了人们的关注。然而,噬菌体和细菌之间正在进行的进化军备竞赛已经推动了噬菌体防御系统在细菌群体中的积累,这可能会损害噬菌体应用的有效性和普遍性。最近,形成核的噬菌体被发现并归类为新建立的噬菌体家族“嵌合病毒科”。嵌合病毒协调高度组织化的、以核为基础的复制,将噬菌体DNA从宿主防御中分离出来,从而提高复制效率,并赋予对多种宿主防御的抵抗力。它们独特的复制策略和亚细胞组织远远超过经典噬菌体,使它们成为具有优越治疗潜力和生物控制能力的新一类“下一代噬菌体”的候选者。这篇综述将涵盖嵌合体病毒发现的现状,强调它们与细菌病原体的联系,独特的复制机制,以及与细菌防御的相互作用。此外,它为基于嵌合病毒的治疗应用提供了见解。
{"title":"Nucleus-forming phages: from subcellular organization and viral–host interplay to prospects for phage applications","authors":"Vorrapon Chaikeeratisak ,&nbsp;Poochit Nonejuie ,&nbsp;Chase J Morgan","doi":"10.1016/j.mib.2025.102698","DOIUrl":"10.1016/j.mib.2025.102698","url":null,"abstract":"<div><div>The increasing emergence of multidrug-resistant bacterial infections poses a major threat to humankind, with 10 million deaths predicted in 2050 as a result. Phage therapy has therefore regained attention as a promising approach to combat these pathogens. However, the ongoing evolutionary arms race between phages and bacteria has driven the accumulation of phage defense systems in bacterial populations, which can compromise the efficacy and generalizability of phage applications. Recently, nucleus-forming phages have been discovered and classified under the newly established phage family ‘Chimalliviridae’. Chimalliviruses orchestrate a highly organized, nucleus-based replication that physically segregates phage DNA from host defenses, thereby enhancing replication efficiency and conferring resistance to a wide array of host defenses. Their unique replication strategy and subcellular organization far exceed that of classical phages, positioning them as candidates for a new class of ‘next-generation phages’ with superior therapeutic potential and biocontrol capabilities. This review will cover the current landscape of chimallivirus discovery, highlighting their association with bacterial pathogens, unique replication machinery, and interaction with bacterial defenses. Furthermore, it provides insights into chimallivirus-based therapeutic applications.</div></div>","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"89 ","pages":"Article 102698"},"PeriodicalIF":7.5,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
tRNAs as toxin targets in phage defence and a focus of counter-defence against abortive infection trna作为噬菌体防御的毒素靶点和对流产感染的反防御焦点
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2025-12-19 DOI: 10.1016/j.mib.2025.102697
Tom J Arrowsmith , Maria Puiu , Tim R Blower
Shutoff of host translation is a common immunity strategy employed by bacteria to defend against predatory bacteriophages. Many bacterial toxin–antitoxin systems specifically target and inactivate tRNAs to achieve translational inhibition, potentially in response to phage infection. Common modes of action include modification, cleavage or re-allocation of target tRNAs. Recent studies have also identified key determinants of specificity for tRNA-targeting toxins. Herein, we discuss toxin action and specificity in the context of phage defence. As a counterpoint, we consider virally encoded tRNAs as counter-defences and drivers of phage evolution.
关闭宿主翻译是细菌防御掠夺性噬菌体的一种常见免疫策略。许多细菌毒素-抗毒素系统特异性靶向并灭活trna以实现翻译抑制,这可能是对噬菌体感染的反应。常见的作用方式包括修饰、切割或重新分配目标trna。最近的研究还确定了trna靶向毒素特异性的关键决定因素。在这里,我们讨论毒素的作用和特异性在噬菌体防御的背景下。与此相反,我们认为病毒编码的trna是噬菌体进化的反防御和驱动因素。
{"title":"tRNAs as toxin targets in phage defence and a focus of counter-defence against abortive infection","authors":"Tom J Arrowsmith ,&nbsp;Maria Puiu ,&nbsp;Tim R Blower","doi":"10.1016/j.mib.2025.102697","DOIUrl":"10.1016/j.mib.2025.102697","url":null,"abstract":"<div><div>Shutoff of host translation is a common immunity strategy employed by bacteria to defend against predatory bacteriophages. Many bacterial toxin–antitoxin systems specifically target and inactivate tRNAs to achieve translational inhibition, potentially in response to phage infection. Common modes of action include modification, cleavage or re-allocation of target tRNAs. Recent studies have also identified key determinants of specificity for tRNA-targeting toxins. Herein, we discuss toxin action and specificity in the context of phage defence. As a counterpoint, we consider virally encoded tRNAs as counter-defences and drivers of phage evolution.</div></div>","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"89 ","pages":"Article 102697"},"PeriodicalIF":7.5,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harnessing ‘phage training’ to bolster the therapeutic potential of bacteriophages 利用“噬菌体训练”来增强噬菌体的治疗潜力。
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2025-12-17 DOI: 10.1016/j.mib.2025.102696
Natasha Torriero-Smith , Benjamin A Rogers , Michael J McDonald , Jeremy J Barr
Bacteriophages (phages) are viruses that selectively prey on bacteria. Their use in treating antimicrobial-resistant bacterial infections is steadily increasing due to the need for alternative therapies. The application of phage therapy is not without its challenges, including difficulties associated with isolating phages against a target strain, the limited infectivity of a phage, the cost and complexity of producing well-characterised phage stocks, and the emergence of phage resistance. The directed adaptation of phage to a specific bacterial target, also known as ‘phage training’, leverages the natural evolutionary capacity of phages and can be used to bolster their bacterial killing abilities. Phage training dates back almost as far as phage therapy itself, being used to expand the therapeutic use of phages. Numerous reports showcase the success and benefits of phage training in vitro and its potential to operate effectively within the framework of phage therapy. However, the time needed to train a given phage, followed by genotypic and phenotypic characterisation of both pre- and post-trained phages, is a major limitation. Here, we explore oversights of the phage training process and propose some considerations and solutions to help drive the field forward to enable its feasible integration into phage therapy.
噬菌体是一种选择性捕食细菌的病毒。由于需要替代疗法,它们在治疗耐抗生素细菌感染方面的应用正在稳步增加。噬菌体治疗的应用并非没有挑战,包括与分离噬菌体对抗目标菌株相关的困难,噬菌体的有限传染性,生产具有良好特征的噬菌体库存的成本和复杂性,以及噬菌体耐药性的出现。噬菌体对特定细菌靶标的定向适应,也被称为“噬菌体训练”,利用了噬菌体的自然进化能力,可用于增强其杀死细菌的能力。噬菌体训练几乎可以追溯到噬菌体治疗本身,用于扩大噬菌体的治疗用途。许多报告展示了噬菌体体外训练的成功和益处,以及它在噬菌体治疗框架内有效运作的潜力。然而,训练给定噬菌体所需的时间,以及随后对训练前后的噬菌体进行基因型和表型表征是一个主要的限制。在这里,我们探讨了噬菌体训练过程的疏忽,并提出了一些考虑和解决方案,以帮助推动该领域向前发展,使其能够可行地整合到噬菌体治疗中。
{"title":"Harnessing ‘phage training’ to bolster the therapeutic potential of bacteriophages","authors":"Natasha Torriero-Smith ,&nbsp;Benjamin A Rogers ,&nbsp;Michael J McDonald ,&nbsp;Jeremy J Barr","doi":"10.1016/j.mib.2025.102696","DOIUrl":"10.1016/j.mib.2025.102696","url":null,"abstract":"<div><div>Bacteriophages (phages) are viruses that selectively prey on bacteria. Their use in treating antimicrobial-resistant bacterial infections is steadily increasing due to the need for alternative therapies. The application of phage therapy is not without its challenges, including difficulties associated with isolating phages against a target strain, the limited infectivity of a phage, the cost and complexity of producing well-characterised phage stocks, and the emergence of phage resistance. The directed adaptation of phage to a specific bacterial target, also known as ‘phage training’, leverages the natural evolutionary capacity of phages and can be used to bolster their bacterial killing abilities. Phage training dates back almost as far as phage therapy itself, being used to expand the therapeutic use of phages. Numerous reports showcase the success and benefits of phage training <em>in vitro</em> and its potential to operate effectively within the framework of phage therapy. However, the time needed to train a given phage, followed by genotypic and phenotypic characterisation of both pre- and post-trained phages, is a major limitation. Here, we explore oversights of the phage training process and propose some considerations and solutions to help drive the field forward to enable its feasible integration into phage therapy.</div></div>","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"89 ","pages":"Article 102696"},"PeriodicalIF":7.5,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging governance considerations for the deployment of genetically engineered microbes 对基因工程微生物部署的新兴治理考虑
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2025-12-13 DOI: 10.1016/j.mib.2025.102685
Avery M Brewer , Dalton R George , Emma K Frow
In this review, we identify emerging trends in the governance and policy landscape surrounding the real-world deployment of genetically engineered microbes (GEMs), focusing on the United States and Europe. A recent wave of commercialized GEMs in the US suggests that interest in developing GEMs for open release might be on the rise, after a 40-year period of very low commercial activity. GEMs are receiving renewed attention for their potential roles in agriculture, sustainable manufacturing, biosensing, environmental restoration, energy production, and human health. Advances in genetic modification technologies, combined with the growing number of possible open release applications for GEMs, stand to challenge existing governance frameworks in several ways. First, the feasibility of either strict product- or process-based regulatory frameworks for biotechnology is being increasingly tested. Second, the desirability of long-term persistence and ecological action of GEMs in some application contexts complicates the logic of typical risk assessments for deliberate release of genetically modified organisms. Synergistic, long-term, and indirect impacts of open release are challenging to reliably predict and call for risk assessment methods able to accommodate high levels of uncertainty or ignorance. Third, increasing variety in application types for GEMs is likely to yield new business models and routes to market. Approaches such as direct-to-consumer marketing raise challenging questions around stewardship, consent, transborder movement, and monitoring of GEMs. This constellation of issues will benefit from interdisciplinary research and stakeholder deliberation at local, national, and international levels to promote robust and adaptable GEM governance in the coming decades.
在这篇综述中,我们确定了围绕现实世界中基因工程微生物(GEMs)部署的治理和政策格局的新趋势,重点是美国和欧洲。在经历了40年的低商业活动之后,美国最近一波商业化的GEMs表明,开发公开发布的GEMs的兴趣可能正在上升。GEMs因其在农业、可持续制造、生物传感、环境恢复、能源生产和人类健康方面的潜在作用而重新受到关注。遗传修饰技术的进步,结合gem可能的开放发布应用程序的数量的增长,将在几个方面挑战现有的治理框架。首先,严格的基于产品或基于过程的生物技术管理框架的可行性正在受到越来越多的考验。其次,在某些应用环境中,GEMs的长期持久性和生态作用的可取性使故意释放转基因生物的典型风险评估的逻辑复杂化。开放释放的协同、长期和间接影响是具有挑战性的,难以可靠地预测,并且需要能够适应高度不确定性或无知的风险评估方法。第三,GEMs应用程序类型的增加可能产生新的商业模式和进入市场的途径。直接面向消费者的营销等方法提出了关于gem管理、许可、跨境移动和监控等具有挑战性的问题。这一系列问题将受益于地方、国家和国际层面的跨学科研究和利益相关者审议,以促进未来几十年健全和适应性强的创业板治理。
{"title":"Emerging governance considerations for the deployment of genetically engineered microbes","authors":"Avery M Brewer ,&nbsp;Dalton R George ,&nbsp;Emma K Frow","doi":"10.1016/j.mib.2025.102685","DOIUrl":"10.1016/j.mib.2025.102685","url":null,"abstract":"<div><div>In this review, we identify emerging trends in the governance and policy landscape surrounding the real-world deployment of genetically engineered microbes (GEMs), focusing on the United States and Europe. A recent wave of commercialized GEMs in the US suggests that interest in developing GEMs for open release might be on the rise, after a 40-year period of very low commercial activity. GEMs are receiving renewed attention for their potential roles in agriculture, sustainable manufacturing, biosensing, environmental restoration, energy production, and human health. Advances in genetic modification technologies, combined with the growing number of possible open release applications for GEMs, stand to challenge existing governance frameworks in several ways. First, the feasibility of either strict product- or process-based regulatory frameworks for biotechnology is being increasingly tested. Second, the desirability of long-term persistence and ecological action of GEMs in some application contexts complicates the logic of typical risk assessments for deliberate release of genetically modified organisms. Synergistic, long-term, and indirect impacts of open release are challenging to reliably predict and call for risk assessment methods able to accommodate high levels of uncertainty or ignorance. Third, increasing variety in application types for GEMs is likely to yield new business models and routes to market. Approaches such as direct-to-consumer marketing raise challenging questions around stewardship, consent, transborder movement, and monitoring of GEMs. This constellation of issues will benefit from interdisciplinary research and stakeholder deliberation at local, national, and international levels to promote robust and adaptable GEM governance in the coming decades.</div></div>","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"89 ","pages":"Article 102685"},"PeriodicalIF":7.5,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145733933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Assembly and maturation of methyl-coenzyme M reductase in methanogenic archaea” [Curr Opin Microbiol, 87 (2025) 102637] “甲基辅酶M还原酶在产甲烷古菌中的组装和成熟”[j] .微生物学报,87(2025):102637。
IF 7.5 2区 生物学 Q1 MICROBIOLOGY Pub Date : 2025-12-11 DOI: 10.1016/j.mib.2025.102684
Sophia A Adler , Grayson L Chadwick , Dipti D Nayak
{"title":"Corrigendum to “Assembly and maturation of methyl-coenzyme M reductase in methanogenic archaea” [Curr Opin Microbiol, 87 (2025) 102637]","authors":"Sophia A Adler ,&nbsp;Grayson L Chadwick ,&nbsp;Dipti D Nayak","doi":"10.1016/j.mib.2025.102684","DOIUrl":"10.1016/j.mib.2025.102684","url":null,"abstract":"","PeriodicalId":10921,"journal":{"name":"Current opinion in microbiology","volume":"89 ","pages":"Article 102684"},"PeriodicalIF":7.5,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145733934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current opinion in microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1